InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Explore the full record of transactions filed by King Andrew James, Directeur Scientifique. Insider active across 1 companies, notably Chinook Therapeutics, INC.. In total, 9 reports have been published. Total volume traded: €29k. The latest transaction was filed on 11 April 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations9 total
€1,6095,000 shares@ €0.32184.8% of flow
Common Stock
SEC:0001209191-22-024324:0·
€28,5932,500 shares@ €11.437186.0% of flow
Common Stock
SEC:0001209191-22-012315:0·
6,801 shares
Common Stock
SEC:0001209191-22-009564:0·
€7662,500 shares@ €0.306450.4% of flow
Common Stock
SEC:0001209191-22-008937·
€7662,500 shares@ €0.30642.3% of flow
Common Stock
SEC:0001209191-22-008937:0·
€7552,500 shares@ €0.301949.6% of flow
Common Stock
SEC:0001209191-21-064363·
€7552,500 shares@ €0.30192.3% of flow
Common Stock
SEC:0001209191-21-064363:0·
10,151 shares
Common Stock
SEC:0001209191-21-060112·
10,151 shares
Common Stock
SEC:0001209191-21-060112:0·
9 of 9 declarations
About King Andrew James
Andrew James King is the Chief Scientific Officer of Chinook Therapeutics, Inc. In this role, he is responsible for overseeing the company's research and development initiatives, ensuring that scientific projects align with strategic goals. His expertise in the scientific field is essential for guiding innovation and the development of new treatments.
